Biohaven Ltd. BHVN / USD Stock

Overview Charts & Stats for the Selected Time Period

This overview page provides a quick summary of the selected assets, including their latest prices, price changes, market capitalization changes, and more.

Settings

Asset BHVN / USD

Latest Price 11.480

Price Change % Calculating...

Price Change X Calculating...

Up Days Calculating...

Down Days Calculating...

Avg Up Day % Calculating...

Avg Down Day % Calculating...

Median Up Day % Calculating...

Median Down Day % Calculating...

Volatility % 6.03%

Win Rate % 45.3%

CAGR % -81.29%

Best Day % +22.04%

Worst Day % -40.22%

Max Drawdown % -79.05%

Period High 37.18

Period Low 7.79

From High % -69.1%

From Low % +47.4%

Sharpe Ratio -0.04

Days >Avg % 31.6%

Total Volume 641,846,800

Volume: 2026-02-17

Aggregate Volume: 247 Days

Price Chart Percentage Gains

The price chart compares the percentage returns for each asset in the given time period. Each starts out at 0% at the x axis left most position.

Price Overlay ChartPercentage Gains

The overlay price chart displays the price movements of each asset over the selected period, using individual y-axes for each. This allows for an easy comparison of assets with different magnitudes, making it great for identifying correlations.

Volume Chart Daily Volume

This volume chart shows the daily volume for each asset.

Learn More

This page just gave you an overview, you might also want to check out the comprehensive stats, historical, correlation, volatility, and price projection pages.

What is Biohaven Ltd.?

This biopharmaceutical company focuses on developing and commercializing therapies for neurological diseases. Its primary therapeutic areas include migraine, rare diseases, and other neurological conditions. The company's most prominent product is a CGRP receptor antagonist approved for the acute treatment of migraine in adults. It also has a pipeline of investigational drugs targeting various neurological disorders. Operating within the biotechnology and pharmaceutical sector, the company aims to address unmet medical needs in a challenging and highly regulated market. Its strategy involves both internal research and development and strategic partnerships or acquisitions. The company seeks to establish a strong market presence by offering innovative treatments that improve patient outcomes and quality of life for individuals suffering from debilitating neurological conditions. This focus positions it within a competitive landscape but also within a growing segment of the healthcare industry driven by advancements in neuroscience.

🤖 AI Analysis

Model:

Ask me anything about the data on this page. I can help explain metrics, identify patterns, or answer specific questions.

Data sources

Trade hundreds of crypto perpetual futures